ZANTAC 300
LOE ApproachingNDAORALTABLET
Approved
Jun 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 49m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ZANTAC 300 is an oral tablet histamine H2-receptor antagonist approved in 1983 for gastrointestinal acid-related disorders. The drug reduces gastric acid secretion and is indicated for conditions such as peptic ulcer disease and gastroesophageal reflux disease (GERD). It represents a foundational class in GI therapeutics, though mechanism of action and specific indications are not detailed in current records.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30/100), signaling reduced team investment and potential restructuring of the brand commercialization function.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ZANTAC 300 in a LOE-approaching environment offers limited career growth and advancement opportunities; roles are primarily defensive and focused on managing decline. Professionals on this product should view it as a learning opportunity in lifecycle management while actively developing expertise in growth-stage franchises to support long-term career progression.
Brand Manager
Worked on ZANTAC 300 at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.